Clinical Trial

The Effect Of Methylphenıdate Treatment On Neuroınflammatıon Levels In Chıldren Wıth Attentıon Defıcıt Hyperactıvıty Dısorder

Completed
View on ClinicalTrials.gov →
Summary
The aim of this study was to investigate the effect of treatment of ADHD with methylphenidate on neuroinflammation by examining the levels of Interleukin-6 (IL-6), S100B, Claudin-5 in serum samples of patients who were diagnosed with attention deficit hyperactivity disorder (ADHD) and started or planned to start methylphenidate for treatment as per routine, at month 0 before the initiation of methylphenidate treatment and at month 3 after the initiation of treatment.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-06-19; most recent amendment 2026-02-11.
Status change: Recruiting → Completed 2026-01-09
Status change: Not Yet Recruiting → Recruiting 2025-07-24
Trial Details
NCT Number NCT07041333
Lead Sponsor Enes Faruk ALTUNKILIÇ
Conditions Attention Deficit Disorder With Hyperactivity (ADHD)
Enrollment 57 participants
Start Date 2025-07-14
Primary Completion 2025-10-19 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-24